Attenuated and lethal variants of pichindé virus induce differential patterns of NF-κB activation suggesting a potential target for novel therapeutics

Viral Immunology

Volumn 22, Issue 6, 2009, Pages 457-462

  Bowick, Gavin C ^a,b   Fennewald, Susan M ^a,b   Zhang, Lihong ^a,b   Yang, Xianbin ^b   Aronson, Judith F ^a,b   Shope, Robert E ^a,b   Luxon, Bruce A ^a,b   Gorenstein, David G ^a,b   Herzog, Norbert K ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMODIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HOST; MONOCYTE; MOUSE; NONHUMAN; PICHINDE ARENAVIRUS; SIGNAL TRANSDUCTION; VIRUS ATTENUATION; VIRUS INFECTION;

ANIMALS; ARENAVIRIDAE INFECTIONS; DEFECTIVE VIRUSES; DRUG DELIVERY SYSTEMS; MICE; MONOCYTES; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PHOSPHORYLATION; PICHINDE VIRUS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; VIRULENCE;

LASSA VIRUS; PICHINDE VIRUS;

EID: 71449089458     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0034     Document Type: Article

References (31)

1. Aronson JF, Herzog NK, and Jerrells TR: Pathological and virological features of arenavirus disease in guinea-pigs- comparison of 2 Pichinde virus-strains. Am J Pathol 1994;145:228-235.
2. Aronson JF, Herzog NK, and Jerrells TR: Tumor-necrosisfactor and the pathogenesis of Pichinde virus-infection in guinea-pigs. Am J Trop Med Hyg 1995;52:262-269.
3. Bowick GC, Fennewald SM, Elsom BL, Aronson JF, Luxon BA, Gorenstein DG, and Herzog NK: Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections. J Virol 2006;80:10248-10252.
4. Bowick GC, Fennewald SM, Scott EP, et al.: Identification of differentially activated cell-signaling networks associated with Pichinde virus pathogenesis by using systems kinomics. J Virol 2007;81:1923-1933.
5. Bowick GC, Spratt HM, Hogg AE, et al.: Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infection. J Virol 2009;83:687-700.
6. Dejean CB, Ayerra BL, and Teyssie AR: Interferon response in the guinea pig infected with Junin virus. J Med Virol 1987;23:83-91.
7. Djavani M, Crasta OR, Zhang Y, et al.: Gene expression in primate liver during viral hemorrhagic fever. J Virol 2009; 6:20.
8. Djavani MM, Crasta OR, Zapata JC, et al.: Early blood profiles of virus infection in a monkey model for Lassa fever. J Virol 2007;81:7960-7973.
9. Driessler F, Venstrom K, Sabat R, Asadullah K, and Schottelius AJ: Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol 2004;135:64-73.
10. Dyer RB, and Herzog NK: Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cellline. Biotechniques 1995;19:192-195.
11. Fennewald SM, Aronson JF, Zhang L, and Herzog NK: Alterations in NF-kappa b and RBP-J kappa by arenavirus infection of macrophages in vitro and in vivo. J Virol 2002;76:1154-1162.
12. Fennewald SM, Scott EP, Zhang LH, et al.: Thioaptamer decoy targeting of ap-1 proteins influences cytokine gene expression and the outcome of arenavirus infections. J Gen Virol 2007;88:981-990.
13. Ferreira V, Tarantino N, and Korner M: Discrimination between rela and relb transcriptional regulation by a dominant negative mutant of IkappaBalpha. J Biol Chem 1998;273: 592-599.
14. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, and Siebenlist U: The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 1992;359:339-342.
15. Gil S, Spagnuolo-Weaver M, Canals A, et al.: Expression at mRNA level of cytokines and a238l gene in porcine bloodderived macrophages infected in vitro with African swine fever virus (ASFV) isolates of different virulence. Arch Virol 2003;148:2077-2097.
16. Gomez del Moral M, Ortuno E, Fernandez-Zapatero P, Alonso F, Alonso C, Ezquerra A, and Dominguez J: African swine fever virus infection induces tumor necrosis factor alpha production: implications in pathogenesis. J Virol 1999;73:2173-2180.
17. Hinata K, Gervin AM, Jennifer ZY, and Khavari PA: Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin. Oncogene 2003;22:1955-1964.
18. Jahrling PB, Hesse RA, Rhoderick JB, Elwell MA, and Moe JB: Pathogenesis of a Pichinde virus-strain adapted to produce lethal infections in guinea-pigs. Infect Immun 1981;32:872-880.
19. King DJ, Bassett SE, Li X, Fennewald SA, Herzog NK, Luxon BA, Shope R, and Gorenstein DG: Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B rela(p65) and p50. Biochemistry 2002;41:9696-9706.
20. Lukashevich IS, Maryankova R, Vladyko AS, et al.: Lassa and Mopeia virus replication in human monocytes/ macrophages and in endothelial cells: different effects on IL- 8 and TNF-alpha gene expression. J Med Virol 1999;59:552-560.
21. Mandrekar P, Catalano D, and Szabo G: Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. Alcohol Clin Exp Res 1997;21:988-994.
22. Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, and de la Torre JC: Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 2007;81: 12696-12703.
23. Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, and de la Torre JC: Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 2006;80:9192-9199.
24. Neumann M, and Naumann M: Beyond IkappaBs: alternative regulation of NF-kappaB activity. FASEB J 2007;21: 2642-2654.
25. Perkins ND: Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 2006;25:6717-6730.
26. Vela EM, Bowick GC, Herzog NK, and Aronson JF: Exploring kinase inhibitors as therapies for human arenavirus infections. Future Virol 2008;3:243-251.
27. Vela EM, Bowick GC, Herzog NK, and Aronson JF: Genistein treatment of cells inhibits arenavirus infection. Antiviral Res 2008;77:153-156.
28. Villinger F, Rollin PE, Brar SS, et al.: Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 1999;179(Suppl 1):S188-S191.
29. Volk DE, Yang X, Fennewald SM, et al.: Solution structure and design of dithiophosphate backbone aptamers targetingtranscription factor NF-kappaB. Bioorg Chem 2002;30: 396-419.
30. Wang H, Yang X, Bowick GC, Herzog NK, Luxon BA, Lomas LO, and Gorenstein DG: Identification of proteins bound to a thioaptamer probe on a proteomics array. Biochem Biophys Res Commun 2006;347:586-593.
31. Yang X, Fennewald S, Luxon BA, Aronson J, Herzog NK, and Gorenstein DG: Aptamers containing thymidine 30-ophosphorodithioates: synthesis and binding to nuclear factor-kappaB. Bioorg Med Chem Lett 1999;9:3357-3362.